331 related articles for article (PubMed ID: 9822092)
21. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Mayroudi MC; Boudoulas H
Coron Artery Dis; 1996 Nov; 7(11):843-50. PubMed ID: 8993943
[TBL] [Abstract][Full Text] [Related]
22. Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.
Karpe F; Taskinen MR; Nieminen MS; Frick MH; Kesäniemi YA; Pasternack A; Hamsten A; Syvänne M
Atherosclerosis; 2001 Jul; 157(1):181-7. PubMed ID: 11427219
[TBL] [Abstract][Full Text] [Related]
23. The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
Winocour PH; Durrington PN; Bhatagnar D; Ishola M; Mackness M; Arrol S; Anderson DC
Atherosclerosis; 1992 Mar; 93(1-2):83-94. PubMed ID: 1596307
[TBL] [Abstract][Full Text] [Related]
24. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
[TBL] [Abstract][Full Text] [Related]
25. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
26. Marked removal of bezafibrate-induced high-density lipoprotein-cholesterol by low-density lipoprotein apheresis.
Kawano M; Kuroda Y; Terao M; Yaginuma T; Kawakami M; Kanazawa Y
Clin Chim Acta; 2002 Apr; 318(1-2):91-5. PubMed ID: 11880117
[TBL] [Abstract][Full Text] [Related]
27. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
[TBL] [Abstract][Full Text] [Related]
28. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.
Alaupovic P; Mack WJ; Knight-Gibson C; Hodis HN
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):715-22. PubMed ID: 9108785
[TBL] [Abstract][Full Text] [Related]
29. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ
J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975
[TBL] [Abstract][Full Text] [Related]
30. Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients.
Kempen HJ; Gomaraschi M; Simonelli S; Calabresi L; Moerland M; Otvos J; Jeyarajah E; Kallend D; Wijngaard PLJ
Atherosclerosis; 2016 Dec; 255():17-24. PubMed ID: 27816804
[TBL] [Abstract][Full Text] [Related]
31. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
[TBL] [Abstract][Full Text] [Related]
32. [BECAIT [Bezafibrate Coronary Atherosclerosis Intervention Trial]].
Yoshino G; Hirano T; Kazumi T
Nihon Rinsho; 2001 Mar; 59 Suppl 3():433-5. PubMed ID: 11347109
[No Abstract] [Full Text] [Related]
33. Lipoproteins and apolipoproteins in the young and familial risk of coronary atherosclerosis.
Uiterwaal CS; Witteman JC; van Stiphout WA; Krauss XH; de Bruijn AM; Hofman A; Grobbee DE
Atherosclerosis; 1996 May; 122(2):235-44. PubMed ID: 8769686
[TBL] [Abstract][Full Text] [Related]
34. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
[TBL] [Abstract][Full Text] [Related]
35. Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate.
Mordasini R; Riesen W; Oster P; Keller M; Middelhoff G; Lang PD
Atherosclerosis; 1981 Oct; 40(2):153-8. PubMed ID: 6796096
[TBL] [Abstract][Full Text] [Related]
36. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
Tornvall P; Båvenholm P; Landou C; de Faire U; Hamsten A
Circulation; 1993 Nov; 88(5 Pt 1):2180-9. PubMed ID: 8222113
[TBL] [Abstract][Full Text] [Related]
37. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
Kempen HJ; van Gent CM; Buytenhek R; Buis B
J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
[TBL] [Abstract][Full Text] [Related]
38. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
[TBL] [Abstract][Full Text] [Related]
39. Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease.
Williams PT; Zhao XQ; Marcovina SM; Otvos JD; Brown BG; Krauss RM
Atherosclerosis; 2014 Apr; 233(2):713-720. PubMed ID: 24603218
[TBL] [Abstract][Full Text] [Related]
40. Corn oil intake favorably impacts lipoprotein cholesterol, apolipoprotein and lipoprotein particle levels compared with extra-virgin olive oil.
Maki KC; Lawless AL; Kelley KM; Kaden VN; Geiger CJ; Palacios OM; Dicklin MR
Eur J Clin Nutr; 2017 Jan; 71(1):33-38. PubMed ID: 27677368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
